4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

9.32

-0.17 (-1.79%)

Feb 4, 2026, 11:01 AM EST - Market open

4D Molecular Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	475	257	866	719	705	1,098
Market Cap Growth	119.74%	-70.27%	20.40%	2.03%	-35.79%	-
Enterprise Value	134	-268	562	497	478	1,185
Last Close Price	9.49	5.57	20.26	22.21	21.94	41.45
PS Ratio	4033.87	6959.14	41.80	229.93	39.09	80.68
PB Ratio	1.20	0.50	2.81	3.11	2.21	4.28
P/TBV Ratio	1.31	0.50	2.81	3.11	2.21	4.28
EV/Sales Ratio	1117.50	-	27.10	158.89	26.50	87.05
Debt / Equity Ratio	0.06	0.05	0.05	0.07	0.05	-
Asset Turnover	0	0	0.07	0.01	0.06	0.08
Quick Ratio	8.22	14.58	15.21	13.58	15.21	16.62
Current Ratio	8.42	14.92	15.65	14.02	15.69	16.88
Return on Equity (ROE)	-45.38%	-39.31%	-37.41%	-39.06%	-24.79%	-39.59%
Return on Assets (ROA)	-27.64%	-26.08%	-23.45%	-22.35%	-13.89%	-20.44%
Return on Capital Employed (ROCE)	-58.70%	-35.40%	-35.20%	-44.70%	-21.20%	-20.90%
Earnings Yield	-43.21%	-62.48%	-11.64%	-14.94%	-10.11%	-5.16%
FCF Yield	-38.23%	-53.74%	-9.07%	-13.65%	-11.10%	-4.73%
Buyback Yield / Dilution	-10.07%	-37.86%	-20.95%	-16.66%	-331.23%	-25.05%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q